• 1. Emerging themes in soft matter: responsive and active soft materials
  Julia M. Yeomans Soft Matter, 2010,6, 703-704
• 2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 3. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 4. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 5. Distinguishing between polymorphic forms of linezolid by solid-phase electronic and vibrational circular dichroism?
  Jadwiga Frelek,Marcin Górecki,Marta ?aszcz,Agata Suszczyńska,Elemér Vass,Wojciech J. Szczepek Chem. Commun., 2012,48, 5295-5297

Research Briefing on 3-(Tetrahydrofurfuryloxypropyl)Heptamethyltrisiloxane (CAS: 1361237-41-3) in Chemical and Biomedical Applications

Recent advancements in the field of chemical and biomedical research have highlighted the growing importance of organosilicon compounds, particularly 3-(Tetrahydrofurfuryloxypropyl)Heptamethyltrisiloxane (CAS: 1361237-41-3). This compound, characterized by its unique siloxane backbone and tetrahydrofurfuryloxypropyl functional group, has demonstrated significant potential in various applications, including drug delivery, surface modification, and biomedical coatings. The following briefing synthesizes the latest research findings and technological developments related to this compound, providing a comprehensive overview of its current and prospective uses.

One of the most notable applications of 3-(Tetrahydrofurfuryloxypropyl)Heptamethyltrisiloxane is in the development of advanced drug delivery systems. Recent studies have explored its role as a carrier molecule due to its amphiphilic nature, which enables the solubilization of both hydrophilic and hydrophobic drugs. Research published in the Journal of Controlled Release (2023) demonstrated that this compound enhances the bioavailability of poorly water-soluble drugs by forming stable micellar structures. Furthermore, its biocompatibility and low toxicity profile make it an attractive candidate for in vivo applications.

In addition to drug delivery, 3-(Tetrahydrofurfuryloxypropyl)Heptamethyltrisiloxane has been investigated for its surface-modifying properties. A study in ACS Applied Materials & Interfaces (2024) reported that coatings incorporating this compound exhibit superior anti-fouling characteristics, reducing protein adsorption and bacterial adhesion on medical devices. The researchers attributed these properties to the compound's ability to form a highly ordered, hydrophobic surface layer, which minimizes interactions with biological macromolecules. This finding has significant implications for the development of next-generation biomedical implants and diagnostic tools.

Another emerging area of research involves the use of 3-(Tetrahydrofurfuryloxypropyl)Heptamethyltrisiloxane in the synthesis of hybrid materials. A recent publication in Advanced Functional Materials (2023) detailed its incorporation into silica-based nanocomposites, resulting in materials with tunable mechanical and thermal properties. These hybrids have shown promise in applications ranging from tissue engineering scaffolds to controlled-release matrices, underscoring the versatility of this compound in materials science.

Despite these promising developments, challenges remain in the large-scale production and regulatory approval of products containing 3-(Tetrahydrofurfuryloxypropyl)Heptamethyltrisiloxane. Current research efforts are focused on optimizing synthetic routes to improve yield and purity, as well as conducting comprehensive toxicological assessments to ensure safety in clinical applications. Collaborative initiatives between academic institutions and industry partners are expected to accelerate the translation of these findings into commercially viable products.

In conclusion, 3-(Tetrahydrofurfuryloxypropyl)Heptamethyltrisiloxane (CAS: 1361237-41-3) represents a compelling case study in the intersection of chemistry and biomedicine. Its multifunctional properties and broad applicability position it as a key player in the development of innovative therapeutic and diagnostic solutions. Future research should prioritize the elucidation of structure-activity relationships and the exploration of novel formulations to fully unlock its potential in the chemical and biomedical fields.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)